September 08, 2020

Bristol-Myers Squibb Company, et al., Petitioners v. New Mexico, ex rel. Hector Balderas, Attorney General

Track this case

Case overview

Case Number:

20-293

Court:

Supreme Court

Nature of Suit:

Firms

Companies

Sectors & Industries:

View recent docket activity


Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


Coverage

  1. January 11, 2021

    Justices Won't Review Do-Overs Of Whistleblower FCA Cases

    The U.S. Supreme Court on Monday shot down Bristol-Myers Squibb and Sanofi's challenge to a decision that allowed New Mexico to proceed with allegations of unlawful drug marketing even though a whistleblower lost a suit with the same facts.

1 other articles on this case. View all »

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS